{"abstract": "Pfizer is acquiring a small Pennsylvania start-up developing experimental treatments for Type 2 diabetes. Pfizer said yesterday that it would buy BioRexis Pharmaceutical, which has 50 employees and two key drug compounds in early testing, for an undisclosed amount.", "web_url": "https://dealbook.nytimes.com/2007/02/02/pfizer-buys-experimental-drug-start-up/", "snippet": "", "lead_paragraph": "Pfizer is acquiring a small Pennsylvania start-up developing experimental treatments for Type 2 diabetes. Pfizer said yesterday that it would buy BioRexis Pharmaceutical, which has 50 employees and two key drug compounds in early testing, for an undisclosed amount.", "source": "The New York Times", "multimedia": [], "headline": {"main": "Pfizer Buys Experimental Drug Start-Up", "kicker": "DealBook", "content_kicker": null, "print_headline": "", "name": null, "seo": null, "sub": null}, "keywords": [], "pub_date": "2007-02-02T12:27:22+0000", "document_type": "article", "news_desk": "Business", "section_name": "Business Day", "byline": {"original": "By Dealbook", "person": [{"firstname": "Dealbook", "middlename": null, "lastname": "", "qualifier": null, "title": null, "role": "reported", "organization": "", "rank": 1}], "organization": null}, "type_of_material": "News", "_id": "nyt://article/4a287a12-ea7b-554f-9268-4d3d9e2a3c82", "word_count": 45, "uri": "nyt://article/4a287a12-ea7b-554f-9268-4d3d9e2a3c82"}